Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification by Gorre M E, Mohammed M, Ellwood K, Hsu N, Paquette R, Rao P N, Sawyers C L in Science (New York, N.Y.) (2001).

[PMID: 11423618] PubMed

Abstract

Discussed In Paper

Loading...

Dosing Information

No dosing information annotated.